It’s estimated that 90% of retail investors lose money. We help you beat those odds with concise research, education, and more. Click here to see our offerings.
- A commercial-stage biopharma company focused on developing and commercializing therapeutics for debilitating rare, chronic neuromuscular, and neurological diseases
- Partnered with KYE Pharmaceuticals to commercialize Firdapse in Canada